In a recent study, vaccine-enhanced CAR-T cells effectively produced IFN-γ, improving the anti-cancer activity, and actively recruited and activated DCs in the tumors with simultaneous IL-12 secretion, triggering the antigen spreading to prevent antigen-negative tumor escape [124]. Here, IFNG is linked to cancer.